Skip to content

Clinical trials

Observational Post-Acute COVID-19 Syndrome trials in Italy

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Post-Acute COVID-19 Syndrome Phase: Observational Country / region: Italy Clear all

14 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20201
20212
20228
20242
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Unknown status3
Recruiting2
Not yet recruiting1
Withdrawn1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Federico II University2
IRCCS Policlinico S. Donato2
Istituti Clinici Scientifici Maugeri SpA2
Fondazione Policlinico Universitario Agostino Gemelli IRCCS1
IRCCS Azienda Ospedaliera Universitaria San Martino - IST Istituto Nazionale per la Ricerca sul Cancro, Genoa, Italy1
IRCCS San Raffaele1
Maddalena Giannella1
MedicAir Healthcare S.r.l.1
Neuromed IRCCS1
University of L'Aquila1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Post-Acute COVID-19 Syndrome14
COVID-197
Asthma1
Bronchiectasis1
Dyspnea1
Hemostatic Disorders1
Obesity1
Pulmonary Disease, Chronic Obstructive1
Pulmonary Fibrosis1
Respiration Disorders1

Trials

Showing 1 to 14 of 14. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.